126 related articles for article (PubMed ID: 9698028)
21. A prospective controlled study of the efficacy of short-term anticoagulation therapy in patients with deep vein thrombosis of the lower extremity.
AbuRahma AF; Stickler DL; Robinson PA
J Vasc Surg; 1998 Oct; 28(4):630-7. PubMed ID: 9786257
[TBL] [Abstract][Full Text] [Related]
22. [Late sequelae of deep venous thrombosis: a 13-year follow-up of 223 patients].
Eichlisberger R; Frauchiger B; Widmer MT; Widmer LK; Jäger K
Vasa; 1994; 23(3):234-43. PubMed ID: 7975869
[TBL] [Abstract][Full Text] [Related]
23. Long-term, low-dose warfarin among venous thrombosis patients with and without factor V Leiden mutation: rationale and design for the Prevention of Recurrent Venous Thromboembolism (PREVENT) trial.
Ridker PM
Vasc Med; 1998; 3(1):67-73. PubMed ID: 9666536
[TBL] [Abstract][Full Text] [Related]
24. A comparison of 3 and 6 weeks' anticoagulation in the treatment of venous thromboembolism.
Fennerty AG; Dolben J; Thomas P; Backhouse G; Bentley DP; Campbell IA; Routledge PA
Clin Lab Haematol; 1987; 9(1):17-21. PubMed ID: 3581712
[TBL] [Abstract][Full Text] [Related]
25. Comparison of once-daily subcutaneous Fragmin with continuous intravenous unfractionated heparin in the treatment of deep vein thrombosis.
Lindmarker P; Holmström M; Granqvist S; Johnsson H; Lockner D
Thromb Haemost; 1994 Aug; 72(2):186-90. PubMed ID: 7831649
[TBL] [Abstract][Full Text] [Related]
26. Post-thrombotic syndrome after primary event of deep venous thrombosis 10 to 20 years ago.
Ziegler S; Schillinger M; Maca TH; Minar E
Thromb Res; 2001 Jan; 101(2):23-33. PubMed ID: 11342203
[TBL] [Abstract][Full Text] [Related]
27. Adjusted subcutaneous heparin versus warfarin sodium in the long-term treatment of venous thrombosis.
Hull R; Delmore T; Carter C; Hirsh J; Genton E; Gent M; Turpie G; McLaughlin D
N Engl J Med; 1982 Jan; 306(4):189-94. PubMed ID: 7033782
[TBL] [Abstract][Full Text] [Related]
28. Low molecular weight heparin versus warfarin in the prevention of recurrences after deep vein thrombosis.
Pini M; Aiello S; Manotti C; Pattacini C; Quintavalla R; Poli T; Tagliaferri A; Dettori AG
Thromb Haemost; 1994 Aug; 72(2):191-7. PubMed ID: 7831650
[TBL] [Abstract][Full Text] [Related]
29. Intensive initial oral anticoagulation and shorter heparin treatment in deep vein thrombosis.
Schulman S; Lockner D; Bergström K; Blombäck M
Thromb Haemost; 1984 Dec; 52(3):276-80. PubMed ID: 6397871
[TBL] [Abstract][Full Text] [Related]
30. Prospective 12-year follow-up study of clinical and hemodynamic sequelae after deep vein thrombosis in low-risk patients (Zürich study).
Franzeck UK; Schalch I; Jäger KA; Schneider E; Grimm J; Bollinger A
Circulation; 1996 Jan; 93(1):74-9. PubMed ID: 8616945
[TBL] [Abstract][Full Text] [Related]
31. The clinical course of deep-vein thrombosis. Prospective long-term follow-up of 528 symptomatic patients.
Prandoni P; Villalta S; Bagatella P; Rossi L; Marchiori A; Piccioli A; Bernardi E; Girolami B; Simioni P; Girolami A
Haematologica; 1997; 82(4):423-8. PubMed ID: 9299855
[TBL] [Abstract][Full Text] [Related]
32. [Complications and risks associated with an anticoagulation therapy combining low molecular weight heparin and Warfarin after total replacement of large joints--our experience].
Míka P; Behounek J; Skoták M; Nevsímal L
Acta Chir Orthop Traumatol Cech; 2004; 71(4):237-44. PubMed ID: 15456102
[TBL] [Abstract][Full Text] [Related]
33. Withdrawal of warfarin after deep vein thrombosis: effects of a low fixed dose on rebound thrombin generation.
Ascani A; Iorio A; Agnelli G
Blood Coagul Fibrinolysis; 1999 Jul; 10(5):291-5. PubMed ID: 10456621
[TBL] [Abstract][Full Text] [Related]
34. The influence of oral anticoagulation therapy on deep vein thrombosis rates four weeks after total hip replacement.
Caprini JA; Arcelus JI; Motykie G; Kudrna JC; Mokhtee D; Reyna JJ
J Vasc Surg; 1999 Nov; 30(5):813-20. PubMed ID: 10550178
[TBL] [Abstract][Full Text] [Related]
35. The development of persistent thrombotic masses in patients with deep venous thrombosis randomized to long-term anticoagulation treatment.
Vítovec M; Golán L; Roztocil K; Linhart A
Vasa; 2009 Aug; 38(3):238-44. PubMed ID: 19736635
[TBL] [Abstract][Full Text] [Related]
36. Once-daily subcutaneous dalteparin, a low molecular weight heparin, for the initial treatment of acute deep vein thrombosis.
Fiessinger JN; Lopez-Fernandez M; Gatterer E; Granqvist S; Kher A; Olsson CG; Söderberg K
Thromb Haemost; 1996 Aug; 76(2):195-9. PubMed ID: 8865530
[TBL] [Abstract][Full Text] [Related]
37. Residual vein thrombosis for assessing duration of anticoagulation after unprovoked deep vein thrombosis of the lower limbs: the extended DACUS study.
Siragusa S; Malato A; Saccullo G; Iorio A; Di Ianni M; Caracciolo C; Coco LL; Raso S; Santoro M; Guarneri FP; Tuttolomondo A; Pinto A; Pepe I; Casuccio A; Abbadessa V; Licata G; Battista Rini G; Mariani G; Di Fede G
Am J Hematol; 2011 Nov; 86(11):914-7. PubMed ID: 21953853
[TBL] [Abstract][Full Text] [Related]
38. Three months versus one year of oral anticoagulant therapy for idiopathic deep venous thrombosis. Warfarin Optimal Duration Italian Trial Investigators.
Agnelli G; Prandoni P; Santamaria MG; Bagatella P; Iorio A; Bazzan M; Moia M; Guazzaloca G; Bertoldi A; Tomasi C; Scannapieco G; Ageno W;
N Engl J Med; 2001 Jul; 345(3):165-9. PubMed ID: 11463010
[TBL] [Abstract][Full Text] [Related]
39. [Duration of oral anticoagulant therapy in deep venous thrombosis of the lower limbs].
Pinède L
Ann Cardiol Angeiol (Paris); 2002 Jun; 51(3):158-63. PubMed ID: 12471647
[TBL] [Abstract][Full Text] [Related]
40. Anticoagulation period in idiopathic venous thromboembolism. How long is enough?
Farraj RS
Saudi Med J; 2004 Jul; 25(7):848-51. PubMed ID: 15235686
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
